z-logo
Premium
SU‐E‐T‐787: Noncoplanar Intensity‐Modulated Radiation Therapy for Young Female Patients with Mediastinal Lymphoma
Author(s) -
Chen X,
Jin D,
Dai J
Publication year - 2011
Publication title -
medical physics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.473
H-Index - 180
eISSN - 2473-4209
pISSN - 0094-2405
DOI - 10.1118/1.3612751
Subject(s) - medicine , nuclear medicine , radiation therapy , lymphoma , dosimetry , radiology , sagittal plane
Purpose: To propose a new technique, noncoplanar intensity‐modulated radiation therapy (Nonco_IMRT), for young female patients with mediastinal lymphoma, and to evaluate its dosimetric features. Methods: We used to adopt a coplanar IMRT technique (Co_IMRT) to treat patients with mediastinal lymphoma. Typically it has 7 equal‐spaced beams starting from gantry angle of 206°. Large volume of lungs were irradiated, and also bilitaral breasts if the patient were female. Recently, we switched to apply Nonco_IMRT technique which use 2 noncoplanr beams in sagital plane (couch angle 90°, collimator angle 90°,gantry angle 330° and 30°) replace the 2 beams of Co_IMRT that irradiate breasts and lungs directly. Nonco_IMRT was compared against Co_IMRT through a planning comparison study of 15 young female patients. PTV coverage and OAR dose parameters were analyzed. Results: For all patients, the PTV coverage, heart V30 and spinal cord dose were approximately equal between two techniques (P>0.05). But the mean dose and low dose region of bilateral breasts and lungs significantly decreased in noncoplanar IMRT (P<0.05). The reduction of the breast V2.5 and lung V5 was 33.1% and 9.28%, respectively. Conclusions: Compared to conventional Co_IMRT, Nonco_IMRT significantly reduces dose to breasts and lungs, and consequently reduces the possibility of breast second cancer and pulmonary toxity. Besides young female patients,Nonco_IMRT can benefit other mediastinal lymphoma patients as well.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom